enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company Nov 1, 2023 07:30AM
enGene, Inc. and Forbion European Acquisition Corp. (FRBN) Announce Business Combination Agreement May 17, 2023 07:20AM